choroid plexus was not due to non-specific binding or metabolism of lignocaine within or on the choroid plexus.
Introduction
Lignocaine, whose intravenous use is limited by toxicity to the central nervous system, readily enters cerebrospinal fluid from the blood (Usubiaga, Moya, Wikinski, Wikinski & Usubiaga, 1967). Five minutes after the intravenous injection of lignocaine in man, the concentration in intracerebroventricular cerebrospinal fluid is 77% of the concentration in arterial blood and approximately 62% of the concentration in plasma (Usubiaga e! al., 1967; Covino & Vassallo, 1976 The explanation offered for the very rapid appearance of lignocaine in cerebrospinal fluid is that the non-ionic form of lignocaine is lipid soluble and readily passes into cerebrospinal fluid (Usubiaga el al., 1967: Rapoport, 1976 ). The partition coefficient (n-heptane/pH 7.4 buffer) for lignocaine is 2.9 (Covino & Vassallo, 1976) . However, in plasma (pH 7.4), only 30% of lignocaine is non-ionic since the ply, of lignocaine is 7.7 (Covino & Vassallo, 1976) . Hence, only that fraction of non-ionic lignocaine that is not proteinbound could freely penetrate from plasma into cerebrospinal fluid (pH 7.3) (Rapoport, 1976 ).
An alternative explanation for the appearance of lignocaine in cerebrospinal fluid would be that lignocaine is transported, in part, from plasma into cerebrospinal fluid by a carrier-mediated transport system. A possible location for the carrier-mediated transport of lignocaine from blood to cerebrospinal fluid is the choroid plexus, the anatomical locus of the blood-cerebrospinal fluid barrier (Lorenzo & Spector, 1976 ; Rapoport, 1976) . The choroid plexus is known to transport some substances by specific carrier-mediated saturable processes from blood into cerebrospinal fluid (e.g. ascorbic acid, morphine) and from cerebrospinal fluid into blood (e.g. iodide, penicillin and choline) (Wang & Takemori, 1972 ; Lorenzo & Spector, 1976; Rapoport, 1976) . Generally, substances that are transported between blood and cerebrospinal fluid by these carrier-mediated transport processes are accumulated by the isolated choroid plexus in oitro (Lorenzo & Spector, 1976) .
The purpose of the present study was to investigate whether the isolated rabbit choroid
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0143-5221180/010107-0351.50/1 plexus contained an energy-dependent, saturable accumulation system for lignocaine.
Methods
The ability of isolated rabbit choroid plexuses to accumulate I I4C llignocaine (30 mCi/mmol; New England Nuclear, Boston, Massachusetts, U.S.A.) was measured by methods previously described in detail (Spector, 1975) . Individual choroid plexuses (weighing about 6 mg) were obtained from the brains of New Zealand white rabbits (1.5-2.0 kg) that were killed with intravenous pentobarbital (Spector, 1975) . Each choroid plexus was placed in 3 ml of artificial cerebrospinal fluid containing glucose (5 mmol/l) and [14Cllignocaine and, in some cases, other substances. The incubations were carried out in a metabolic shaker at 37°C or I o C under O,/CO, (95 : 5 ) for various times. At the end of the incubation, each choroid plexus was wiped on a glass slide, weighed, and homogenized in 0.5 ml of water. The radioactivity in tissue homogenates and media was determined (Spector, 1975) , and the ratios of tissue to medium radioactivity were calculated by dividing the d.p.m./g of choroid plexus by the d.p.m./ml of medium.
The ability of choroid plexuses that had accumulated [ 14Cllign~caine to release the I 14Cllignocaine was tested. In these experiments, after incubation for 2 rnin in 114Cllignocaine (1.2 pmol/l) at 37OC, the choroid plexuses were rinsed in artificial cerebrospinal fluid (2 s) and transferred for a 10 min incubation into 2 ml of artificial cerebrospinal fluid containing lignocaine (0.1 mmol/l) at 37°C. The percentage of 14C in the release medium divided by the total I4C in the tissue and release medium was determined. The purity of the 114Cllignocaine and the possibility of metabolism of [ I4C llignocaine within the choroid plexus after 5 rnin incubations in artificial cerebrospinal fluid containing I 14Cllignocaine (1.2 pmol/l) were determined chromatographically (New England Nuclear).
To rule out further the possibility of non-specific binding of I 14Cllignocaine to choroid plexus, rabbit choroid plexuses were incubated for 2 rnin in [14C]lignocaine (1 -2 pmol/l) and subsequently homogenized in 1-0 ml of sodium chloride solution (154 mrnol/l) (Lorenzo & Spector, 1973) . Duplicate aliquots (0.1 ml) of supernatant, obtained after centrifugation at 1800g for 10 min, and homogenate were assayed for I T .
Results
The time courses of accumulation (expressed as tissue to medium radioactivity ratios) of I 14C llignocaine at I "C and 37OC are shown in Fig. 1. At 37OC, the mean tissue to medium ratio at 2 rnin (7.81) was 85% of the 45 rnin value. The tissue to medium ratios at 1°C remained below 4.1 at all times tested (Fig. I) . Various substances, including lignocaine, tolazoline, glycinexylidide and dinitrophenol, significantly inhibited I 14C llignocaine accumulation by the isolated choroid plexus. The mean tissue to medium ratios at 2 min in medium containing I I4C llignocaine (1 -2 pmol/l) and various substances, as a percentage of control, were: lignocaine (0. I mmol/l), 75%; lignocaine (2.0 mmol/l), 47%; glycinexylidide (0. I mmoVl), 84%, (2.0 mmol/l), 56%; tolazoline (1 -0 mmol/l), 62%; probenecid (0. I mmol/l), 109%; dinitrophenol (1.0 mmol/l), 50%. All values less than 63% were significantly different from controls (P < There was no significant metabolism of 1 I' C llignocaine within the choroid plexus or medium. There was also no non-specific binding of the I ''Cllignocaine within the choroid plexus when measured by the centrifugation technique. In the supernatants of the choroid plexuses which had accumulated I llignocaine and were homogenized in saline, the concentration of I4C in the supernatant divided by the concentration of I4C in the homogenate was 1.01 f SEM 0.02 (It = 6). This lack of non-specific binding within the choroid plexus was confirmed by the finding that 99 f SEM 1% (11 = 3) of the [14Cllignocaine within the choroid plexus was released into the release medium in the 10 rnin release incubations.
Discussion
The principal finding reported herein is that the isolated choroid plexus concentrates lignocaine by 0.05).
two processes. Greater than 50% o f t h e uptake (with a medium concentration of 1.2 pmol/l) was by a saturable process and presumably depended on energy-production. Approximately 50% of the accumulation was by a non-saturable process and was not inhibited even at 1OC. If \he pH values of the intracellular and extracellular spaces were 7.0 and 7.3 respectively (Lorenzo & Spector, 1973; Rapoport, 1976; Johanson, 1978) , a ratio of 1.3 would be expected since the pK, of lignocaine is 7.7 (Covino & Vassallo, 1976 ) and the intracellular space of the choroid plexus represents 60% of its volume (Lorenzo & Spector, 1973) . However, in these studies, a ratio of approximately 10 was obtained at equilibrium, indicating that other factors beside pH partitioning (active transport, for example) must be operating. The possibility of non-specific binding of the lignocaine within or on the choroid plexus as the principal reason for the rapid accumulation of I I4C llignocaine by choroid plexus is not supported by the centrifugation studies (which showed no non-specific binding) and the ready release of 99%.
Also the rapid accumulation of I I4C]lignocaine by choroid plexus was not due to metabolism since chromatography of alkaline ethanolic extracts of choroid plexus on silica-gel thin-layer plates (in two systems) revealed no lignocaine metabolites.
The system in choroid plexus that accumulates lignocaine is inhibited by other weak bases, e.g. glycinexylidide, a lignocaine metabolite, and tolazoline, but not by probenecid, which inhibits the weak organic acid transport system of choroid plexus in vivo and in vitro (Spector & Lorenzo, 1974) . The relationship between the saturable I I4C Ilignocaine-accumulation system and the accumulation systems in choroid plexus for primary, tertiary and quaternary amines and polyamines remains to be established (Spector, 1975; Rapoport, 1976; Lorenzo & Spector, 1976) .
